Zacks cuts Baxter estimate and Baxter International stock gains 1.49 percent
Published on 10/05/2026 at 16:50 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Baxter International stock was trading at EUR 21.18 at Lang & Schwarz on October 5, 2026 at 4:39 p.m. CEST, up 1.49 percent versus the prior close of EUR 20.87. According to MarketBeat on September 30, 2026, Zacks Research cut Baxter's third-quarter 2026 earnings per share estimate to USD 0.51 from USD 0.53 in a September 28 research note and kept a Hold rating.
Estimate pressure follows a strong quarter
The estimate reduction contrasts with Baxter's second-quarter 2026 performance. MarketBeat reported that adjusted earnings per share reached USD 0.56 in the quarter, exceeding the USD 0.37 consensus by USD 0.19. Revenue totaled USD 2.96 billion, up 5.30 percent from the year-earlier quarter and above the USD 2.80 billion estimate.
The latest figures create a clear split in the story: Baxter delivered a quarterly earnings surprise, while the next-quarter estimate moved lower. For investors, that places the emphasis on whether second-quarter momentum can translate into the company's fiscal 2026 outlook.
Guidance stays above the latest estimate
MarketBeat said Baxter maintained fiscal 2026 adjusted earnings-per-share guidance of USD 1.95 to USD 2.15. The midpoint of that range is USD 2.05, which stands USD 0.01 above the separate full-year consensus estimate of USD 2.04 cited in the same report.
Analyst opinion remains measured. According to MarketBeat on September 30, 2026, 13 analysts held a consensus rating of Hold, including two Buy, nine Hold and two Sell ratings, with an average 12-month target of USD 22.45.
Stock gains while target stays lower
The Lang & Schwarz move leaves the euro quote EUR 0.31 above the prior close, a 1.49 percent daily increase. Primary-market context is different in currency: BAX was quoted at USD 23.77 on October 5, 2026 at 10:49 a.m. ET, while its 52-week range was USD 15.73 to USD 30.00.
Baxter's market capitalization stood at USD 12.3 billion on October 5, 2026. The company operates in healthcare and medical instruments and supplies, with products spanning infusion, nutrition, pharmaceuticals, surgical technologies and connected care.
The further course of trading is shown by the continuously updated real-time quote of Baxter International stock.
Baxter International stock facts
- Company: Baxter International Inc.
- ISIN: US0718131099
- Ticker: BAX
- Primary exchange: NYSE
- Price Lang & Schwarz as of October 5, 2026, 4:39 p.m. CEST: EUR 21.18
- Change versus prior close: plus 1.49 percent
- Prior close Lang & Schwarz September 30, 2026: EUR 20.87
- Market capitalization: USD 12.3 billion (as of October 5, 2026)
- 52-week range: USD 15.73-30.00 (as of October 5, 2026)
- Sector / Industry: Healthcare / Medical instruments and supplies
